Cullinan Associates’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-21,805
| Closed | -$4.01M | – | 242 |
|
|
2021
Q2 | $4.01M | Sell |
21,805
-4,862
| -18% | -$893K | 0.22% | 100 |
|
|
2021
Q1 | $4.08M | Sell |
26,667
-22,065
| -45% | -$3.37M | 0.23% | 100 |
|
|
2020
Q4 | $7.61M | Sell |
48,732
-947
| -2% | -$148K | 0.46% | 63 |
|
|
2020
Q3 | $5.69M | Buy |
49,679
+32,625
| +191% | +$3.73M | 0.37% | 74 |
|
|
2020
Q2 | $1.91M | Buy |
+17,054
| New | +$1.91M | 0.13% | 111 |
|